Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPC5 antisense RNA 2 (GPC5-AS2) is a long non-coding RNA gene located on human chromosome 13, corresponding to genomic region 92,339,794-92,379,536 (GRCh38), on the reverse strand. It has annotated splice variants but its biological function is unknown. No aliases, interacting drugs, or disease associations are documented. This gene should not be confused with related lncRNAs from the same locus, such as GPC5-AS1, which have functional roles in cancer biology[1][5]. If you are seeking a functionally relevant target from this locus, GPC5-AS1 may be of greater biological and therapeutic interest in cancer[1]. GPC5-AS2 itself, as of this writing, is recognized only as a lncRNA gene with little or no functional characterization.
No mechanism is known because no drugs target this lncRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPC5 antisense RNA 2 (GPC5-AS2).